$157.92 Original price was: $157.92.$6.00Current price is: $6.00.
Edited by Wm Kevin Kelly, Edouard Trabulsi, Charles Thomas Jr., and Nicholas Zaorsky, this comprehensive resource reflects the significant advances in prostate cancer treatment over the past five years, emphasizing multidisciplinary collaboration and evidence-based decision-making.
Approximately thirty international leading-edge investigators contribute to this book, providing a thorough review of the entire spectrum of prostate cancer management, from initial screening to novel and experimental treatments that have the potential to significantly impact practice.
The book begins by addressing fundamental issues, including:
These sections cover strategies for improving the accuracy of PSA screening, updates on controversies surrounding the ISUP Modified Gleason Score, and novel molecular and genotype profiling in prostate cancer.
The treatment sections of the book are organized according to the staging of disease, covering:
The book also addresses counseling high-risk patients and incorporates models of care delivery, patient navigation for multidisciplinary care, genomic and risk assessment, and comparative effects of research in treatment decision-making.
This comprehensive resource is designed for all healthcare professionals involved in prostate cancer care, as well as patients, families, and advocates. Its key features include:
With extensive references, this book provides opportunities for additional study and staying current with the latest advances in prostate cancer management.
Language | |
---|---|
Author |
Fermentum tempor cubilia risus tellus massa dis consectetur dolor.
WhatsApp Chat Oniline